ERBB2 and breast cancer: By employing MMTV-Neu mice, which spontaneously develop ER− mammary tumors, bexarotene given for 4 weeks at 80 or 40 mg/kg body weight, suppressed tumor frequency and growth and this was associated with inhibition of cell proliferation and induction of CS (14).